FDA.reportPublic FDA data

273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera]

RxCUI
2055989
RxNorm name
273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera]
Display name
273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera]
Full name
273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eb18194f-2021-41fa-8bdf-31e0c0eb646bAnnovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System [PSN] · 273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera] [SBD] · Annovera 0.15/0.013 MG per 24HR 273 Day Vaginal System [SY]35These highlights do not include all the information needed to use ANNOVERA safely and effectively. See Full Prescribing Information for ANNOVERA ANNOVERA ® (segesterone acetate and ethinyl estradiol vaginal system) Initial U.S. Approval: 201820250423